Universal reference book for medicines
Product name: TERRILYTIN (TERRILYTIN)

Active substance: nonappropriate

Type: Preparation with proteolytic activity for external use

Manufacturer: СПбН��ВС ФМБА (Russia)
Composition, form of production and packaging
Lyophilizate for solution for external use
1 amp.

protease (from the culture of Aspergillus terricola) 100 PES

100 PE - ampoules (10) - packs of cardboard.

Lyophilizate for solution for external use 1 fl.

protease (from the culture of Aspergillus terricola) 100 PES

100 PE - bottles (10) - packs of cardboard.

100 PE - bottles (1) - packs of cardboard.

Lyophilizate for solution for external use 1 amp.

protease (from Aspergillus terricola culture) 200 PES

200 PE - ampoules (10) - packs of cardboard.

Lyophilizate for solution for external use 1 fl.

protease (from Aspergillus terricola culture) 200 PES

200 PE - bottles (1) - packs of cardboard.

INSTRUCTION FOR THE SPECIALIST.

Description of the drug approved by the manufacturer for the printed edition of 2013.

PHARMACHOLOGIC EFFECT

Terylitin is a proteolytic enzyme, the product of the life of a mold fungus.
Its application is based on the ability to cleave necrotic tissue, dilute purulent exudate and blood clots.
INDICATIONS

- purulent wounds;

- burns;

- trophic ulcers;

- bedsores.

DOSING MODE

Outer in the form of a solution containing in 1 ml 40-50 PE (Proteolytic Units).
Before use, the contents of one bottle (200 PE) are dissolved in 4-5 ml, or in 2-2.5 ml (100 PE) of purified water, in 0.9% sodium chloride solution or 0.25% novocaine solution.
The solution is moistened with a sterile napkin, which is applied to the wound and covered with a moisture-proof dressing.

In the treatment of deep burns and other lesions with a large number of necrotic tissues and for the rejection of the scab, Terrylitin is used as a powder, dusting the affected surface.
A sterile napkin, slightly moistened with 0.9% sodium chloride solution or 0.25% novocaine solution, and a moisture-proof bandage are applied on top. Change dressings produced after 1-2 days. At the same time, the areas of necrotic tissue alteration are removed, the surface is washed with a 3% hydrogen peroxide solution, dried and again powdered with Terylitin powder.
Treatment with Terylitin continues until complete rejection of necrotic tissues, melting of fibrinous-purulent deposits and the formation of pure, juicy granulations.

SIDE EFFECT

Allergic reactions.

CONTRAINDICATIONS

bleeding ulcers and wounds;

- Ulceration of malignant tumors;

- pregnancy, lactation;

- simultaneous use of thrombolytic drugs;

- Hypersensitivity to the drug.

With caution: the location of the main blood vessel in the wound;
diseases accompanied by delayed blood clotting.
PREGNANCY AND LACTATION

Contraindicated in pregnancy and lactation.

SPECIAL INSTRUCTIONS

When external application of Terrylitin is necessary to ensure sufficient drainage of the wound.
Do not administer intravenously.
OVERDOSE

Cases of overdose are not described.

DRUG INTERACTION

Terrylitin promotes better penetration into the inflammatory focus of other medicines, is compatible with antibiotics: lincomycin, oxacillin, streptomycin, ampicillin.

The drug is compatible with antimicrobial and other chemotherapeutic agents.

TERMS OF RELEASE FROM PHARMACY

On prescription.

TERMS AND CONDITIONS OF STORAGE

List B. In a dry, the dark place at a temperature of 0 В° C and 10 В° C.
Shelf life - 3 years.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y

Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!